Kazakh-made vaccine QazVac produces high immunity to COVID-19. This is evidenced by extensive clinical trials conducted both by domestic and foreign scientists. Recently, an analysis of the effectiveness of the third phase of the Kazakh medicine was published in a scientific article by the authoritative international clinical journal E-Clinical-Medicine.
“To date, according to the results of our studies by international experts, we receive excellent, very high expert reviews after their thorough check. This demonstrates the high level of Kazakhstan’s science in the field of biosafety, biotechnology and medicine. We are proud,” said Kunsulu Zakarya, Director General of the Research Institute of Biological Safety Problems.
